Table 4.
Summary comparing the results among BTY, ZZ-R 127, LFBK-αVβ6, and IB-RS-2.
| Cell type | |||||
|---|---|---|---|---|---|
| BTY | ZZ-R 127 | LFBK-αVβ6 | IB-RS-2 | ||
| Duration of FMDV sensitivity | 3–4 weeks per batch | >100 passages | >100 passages | >100 passages | |
| Duration of SVDV sensitivity | ND | ND | >100 passages | >100 passages | |
| Sensitivity of cell lines | FMD/A/IRN/24/2012 | 5.8 | 5.7 | 5.8 | 4.3 |
| FMD/O/KUW/4/2016 | 7.9 | 7.7 | 7.7 | 6.4 | |
| (Avg. Log10 TCID50/mL) | SVD/UKG/77/80 | ND | ND | 5.2 | 4.5 |
| Detected FMDV epithelium suspensions | 31/32 | 30/32 | 32/32 | ND | |
| Detected O/CATHAY epithelium suspensions | ND | 2/8 | 8/8 | 1/8 | |
| Detected O/CATHAY diagnostic submissions | 0/26 | ND | 19/26 | 5/26 | |
| Susceptibility to other vesicular viruses | None | VESV, VSV | VESV, VSV, SVV | VESV, VSV, SVV | |
| Matrices causing cytotoxicity | None | Whole blood | Whole blood | Whole blood | |
ND, not done.